Published in Curr Opin Struct Biol on January 04, 2017
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science (1985) 10.42
An evolutionary trace method defines binding surfaces common to protein families. J Mol Biol (1996) 9.31
Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol (2007) 6.11
Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu Rev Biochem (2006) 3.60
The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol Pharmacol (2002) 2.99
The exploration of macrocycles for drug discovery--an underexploited structural class. Nat Rev Drug Discov (2008) 2.94
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation (2008) 2.59
Are protein-protein interfaces more conserved in sequence than the rest of the protein surface? Protein Sci (2004) 2.38
Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov (2012) 2.33
RACK1, A multifaceted scaffolding protein: Structure and function. Cell Commun Signal (2011) 2.16
Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem Biol (2014) 1.95
Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. Curr Opin Chem Biol (2010) 1.91
Peptide therapeutics: current status and future directions. Drug Discov Today (2014) 1.83
Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation (2003) 1.80
Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol (1998) 1.62
Stapled peptides for intracellular drug targets. Methods Enzymol (2012) 1.61
Intracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme. J Biol Chem (1991) 1.51
Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Mol Biol Cell (2010) 1.49
A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci (2012) 1.42
Phage display: practicalities and prospects. Plant Mol Biol (2002) 1.39
Yeast cell-surface display--applications of molecular display. Appl Microbiol Biotechnol (2004) 1.31
Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks. J Biol Chem (2014) 1.19
Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase. Proc Natl Acad Sci U S A (2003) 1.18
Rationally designed peptide regulators of protein kinase C. Trends Endocrinol Metab (2008) 1.17
Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes. Angew Chem Int Ed Engl (2015) 1.17
Isolation of human monoclonal antibodies by mammalian cell display. Proc Natl Acad Sci U S A (2008) 1.14
Fundamental molecular mechanism for the cellular uptake of guanidinium-rich molecules. J Am Chem Soc (2014) 1.08
In vitro display technologies reveal novel biopharmaceutics. FASEB J (2006) 1.07
Decorating microbes: surface display of proteins on Escherichia coli. Trends Biotechnol (2010) 1.06
Druggable protein-protein interactions--from hot spots to hot segments. Curr Opin Chem Biol (2013) 1.00
Clinical Overview of MDM2/X-Targeted Therapies. Front Oncol (2016) 0.98
Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell. Expert Opin Drug Deliv (2015) 0.98
α-Helix mimetics: outwards and upwards. Bioorg Med Chem Lett (2013) 0.97
Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction. Angew Chem Int Ed Engl (2014) 0.96
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium. Invest New Drugs (2010) 0.95
Highly Specific Modulators of Protein Kinase C Localization: Applications to Heart Failure. Drug Discov Today Dis Mech (2010) 0.92
Lambda-display: a powerful tool for antigen discovery. Molecules (2011) 0.90
Phage display as a technology delivering on the promise of peptide drug discovery. Drug Discov Today (2013) 0.87
Advances in phage display technology for drug discovery. Expert Opin Drug Discov (2015) 0.85
High-throughput methods for identification of protein-protein interactions involving short linear motifs. Cell Commun Signal (2015) 0.81
Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies. Mol Biosyst (2015) 0.80
Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo. J Am Chem Soc (2016) 0.80
Alternative modulation of protein-protein interactions by small molecules. Curr Opin Biotechnol (2015) 0.79
Advancement and applications of peptide phage display technology in biomedical science. J Biomed Sci (2016) 0.78
Designing helical peptide inhibitors of protein-protein interactions. Curr Opin Struct Biol (2016) 0.77
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation. J Vis Exp (2016) 0.76
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein-Protein Interaction Inhibitor Reveals a Non-catalytic Role for GAPDH Oligomerization in Cell Death. J Biol Chem (2016) 0.75
Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors. Int J Parasitol Drugs Drug Resist (2016) 0.75
Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics. Angew Chem Int Ed Engl (2016) 0.75